What’s on the MAHA agenda as of mid-2025: Where it’s focused, and what it means for the healthcare industry
Explore the latest on the MAHA agenda and its focus on childhood health. Get an objective take on where the report does—and doesn't—align with the healthcare community, and what it means for industry stakeholders.
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
When we last wrote about “Make America Healthy Again” (MAHA) earlier this year, the initiative was more of a slogan than a true blueprint. And although broad themes were beginning to emerge (i.e., a focus on vaccines and preventive health), it wasn’t yet clear where the administration would focus its initial actions. But less than a year in, the MAHA agenda has evolved rapidly and begun to come into focus: In February 2025, the MAHA Commission was formally launched by Executive Order from President Trump, part of a growing federal emphasis on addressing long-term public health challenges. Its mandate is ambitious: advise the President on the state of Americans’ health, communicate with transparency, and, most specifically, develop strategies to tackle the root causes of a “childhood chronic disease crisis”—today, over 40% of America’s 73 million children have at least one chronic health condition, ranging from obesity and asthma to behavioral disorders and autoimmune disease.

The commission, chaired by Robert F. Kennedy Jr., was given just 100 days to produce an Assessment Report, released in May 2025, with a follow-up Strategy Report initially expected in August, though now delayed.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
This week in healthcare: What happened and what it means
What the 2026 midterm election results mean for healthcare policy
Healthcare policy and payment: What leaders need to know now